STRATA Skin Sciences, Inc. (SSKN)
OTCMKTS
· Delayed Price · Currency is USD
0.270
+0.010 (3.85%)
At close: Mar 6, 2026
STRATA Skin Sciences Revenue
STRATA Skin Sciences had revenue of $6.93M in the quarter ending September 30, 2025, a decrease of -21.23%. This brings the company's revenue in the last twelve months to $30.98M, down -5.19% year-over-year. In the year 2024, STRATA Skin Sciences had annual revenue of $33.56M with 0.61% growth.
Revenue (ttm)
30.98M
Revenue Growth
-5.19%
P/S Ratio
0.05
Revenue / Employee
292.26K
Employees
106
Market Cap
1.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.56M | 204.00K | 0.61% |
| Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
| Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
| Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
| Dec 31, 2020 | 23.09M | -8.50M | -26.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Escalon Medical | 12.31M |
| Sonendo | 31.70M |
| AI Maverick Intel | 92.26K |
| Fuse Medical | 18.40M |
| Vycor Medical | 1.90M |
| Electromedical Technologies | 922.01K |
| Venus Concept | 58.88M |
STRATA Skin Sciences News
- 17 days ago - STRATA Skin Sciences Confirms Nasdaq Delisting - GlobeNewsWire
- 19 days ago - Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser - GlobeNewsWire
- 20 days ago - STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis - GlobeNewsWire
- 26 days ago - Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences - GlobeNewsWire
- 3 months ago - STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico - GlobeNewsWire
- 4 months ago - STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion - GlobeNewsWire
- 4 months ago - STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update - GlobeNewsWire